开发出基于智能手机的ELISA用于血液抗原检测
|
By LabMedica International staff writers Posted on 09 Oct 2017 |

图片:D4检测法的一个原型(照片由Daniel Joh,杜克大学提供)。
一种新的高速、基于芯片的ELISA检测法,依靠一种独特的不粘聚合物涂层检测血液样本中的抗原,以减少对多次培养和清洗过程的需要。
杜克大学(Durham,NC,USA)的研究者们使用一种喷墨打印机向一种经独特的不粘聚合物涂层处理的载玻片上喷一系列抗体。该涂层的功能类似特氟龙,能防止非靶蛋白粘附在玻片表面而造成高水平背景“噪音”。
研究者的“D4检测法”使用一种配对抗体进行检测,并捕捉血液样本中的靶蛋白。玻片上的固定阵列由定殖的捕获抗体和可溶的检测抗体组成,由荧光标记物标记,以允许进行抗原定量(如果有)。将一滴血滴在玻片上,令检测抗体溶解,从阵列中分离出来,并与样品中的靶蛋白结合。然后荧光抗体-抗原对附在玻片上的捕获抗体上。使用一种缓冲液去除未连接在玻片不粘聚合物刷状涂层上的所有蛋白质。使用一种基于检测器系统的智能手机读取检测结果。
作为该检测法准确性的概念验证部分,研究者使用D4检测法测定患者血清中瘦素的水平,并与临床ELISA平台的检测结果进行比较。本研究发现,D4检测法得到的结果与ELISA检测的结果处于同等水平。
“该检测法的现实意义在于聚合物刷状涂层,”资深作者Ashutosh Chilkoti博士,杜克大学的生物医学工程教授说。“聚合物刷允许我们将需要的工具存储在芯片上,同时令设计简单化。”
D4系统的讨论详情可见2017年8月7日网络版的Proceedings of the [U.S.] National Academy of Science([美国]国家科学院学报)。
Related Links:
杜克大学
杜克大学(Durham,NC,USA)的研究者们使用一种喷墨打印机向一种经独特的不粘聚合物涂层处理的载玻片上喷一系列抗体。该涂层的功能类似特氟龙,能防止非靶蛋白粘附在玻片表面而造成高水平背景“噪音”。
研究者的“D4检测法”使用一种配对抗体进行检测,并捕捉血液样本中的靶蛋白。玻片上的固定阵列由定殖的捕获抗体和可溶的检测抗体组成,由荧光标记物标记,以允许进行抗原定量(如果有)。将一滴血滴在玻片上,令检测抗体溶解,从阵列中分离出来,并与样品中的靶蛋白结合。然后荧光抗体-抗原对附在玻片上的捕获抗体上。使用一种缓冲液去除未连接在玻片不粘聚合物刷状涂层上的所有蛋白质。使用一种基于检测器系统的智能手机读取检测结果。
作为该检测法准确性的概念验证部分,研究者使用D4检测法测定患者血清中瘦素的水平,并与临床ELISA平台的检测结果进行比较。本研究发现,D4检测法得到的结果与ELISA检测的结果处于同等水平。
“该检测法的现实意义在于聚合物刷状涂层,”资深作者Ashutosh Chilkoti博士,杜克大学的生物医学工程教授说。“聚合物刷允许我们将需要的工具存储在芯片上,同时令设计简单化。”
D4系统的讨论详情可见2017年8月7日网络版的Proceedings of the [U.S.] National Academy of Science([美国]国家科学院学报)。
Related Links:
杜克大学
Latest 实验室技术 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







